Literature DB >> 17151208

Relationship between cytomegalovirus DNA load in epithelial lining fluid and plasma of lung transplant recipients and analysis of coinfection with Epstein-Barr virus and human herpesvirus 6 in the lung compartment.

Claudia C Bauer1, Peter Jaksch, Stephan W Aberle, Heinrich Haber, Gyoergy Lang, Walter Klepetko, Hanns Hofmann, Elisabeth Puchhammer-Stöckl.   

Abstract

Cytomegalovirus (CMV) is a significant cause of morbidity and mortality in lung transplant recipients (LTRs). The aim of the present study was to elucidate the relationship between the CMV DNA load in the lung compartment and that in plasma. For CMV load determination, the level of CMV DNA in plasma and bronchoalveolar lavage (BAL) samples was measured in a total of 97 paired BAL and plasma samples obtained from 25 LTRs. The original virus concentration in the epithelial lining fluid (ELF) was calculated from the BAL samples by correcting for dilution using the urea dilution method. In addition, the load of Epstein-Barr virus (EBV) and that of human herpesvirus 6 (HHV-6) DNA also were determined in BAL samples, recalculated for their concentrations in the ELF, and compared with the CMV DNA load. CMV DNA was found more frequently and at significantly higher levels in the lung compartment than in plasma (P<0.001, Wilcoxon test), and the CMV load in the ELF was associated with symptomatic CMV disease. EBV and HHV-6 were detected in 43.6% and 21.7% of the ELF samples, respectively. A statistically significant association was found between the CMV and EBV DNA loads in the ELF (P<0.001; Spearman's rho=0.651). Thus, in LTRs, determination of the CMV DNA load in the lung compartment may be advantageous compared to monitoring only viremia. The significant relationship between EBV and CMV DNA loads in the ELF of LTRs and its clinical impact require further investigation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17151208      PMCID: PMC1829057          DOI: 10.1128/JCM.01173-06

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  26 in total

1.  Clinical utility of cytomegalovirus viral load in bronchoalveolar lavage in lung transplant recipients.

Authors:  Roy F Chemaly; Belinda Yen-Lieberman; Jeffrey Chapman; Amy Reilly; B Nebiyou Bekele; Steven M Gordon; Gary W Procop; Nabin Shrestha; Carlos M Isada; Malcolm Decamp; Robin K Avery
Journal:  Am J Transplant       Date:  2005-03       Impact factor: 8.086

2.  Human herpesvirus 6 in bronchalveolar lavage fluid after lung transplantation: a risk factor for bronchiolitis obliterans syndrome?

Authors:  C Neurohr; P Huppmann; H Leuchte; M Schwaiblmair; I Bittmann; G Jaeger; R Hatz; L Frey; P Uberfuhr; B Reichart; J Behr
Journal:  Am J Transplant       Date:  2005-12       Impact factor: 8.086

3.  Herpesvirus infections in solid organ transplant patients at high risk of primary cytomegalovirus disease.

Authors:  Raymund R Razonable; Robert A Brown; Atul Humar; Emma Covington; Emma Alecock; Carlos V Paya
Journal:  J Infect Dis       Date:  2005-09-14       Impact factor: 5.226

4.  The diagnosis of CMV pneumonitis in lung and heart/lung transplant patients by PCR compared with traditional laboratory criteria.

Authors:  G J Buffone; A Frost; T Samo; G J Demmler; P T Cagle; E C Lawrence
Journal:  Transplantation       Date:  1993-08       Impact factor: 4.939

5.  The detection of Epstein-Barr virus DNA in lung tissue from patients with idiopathic pulmonary fibrosis.

Authors:  J P Stewart; J J Egan; A J Ross; B G Kelly; S S Lok; P S Hasleton; A A Woodcock
Journal:  Am J Respir Crit Care Med       Date:  1999-04       Impact factor: 21.405

6.  Factors affecting reactivation of Epstein-Barr virus infection after kidney allograft transplantation.

Authors:  Z R Khameneh; J Soin; M Durlik; M Lao; L Paczek; Z Gaciong
Journal:  Ann Transplant       Date:  1999       Impact factor: 1.530

7.  Quantification of cytomegalovirus DNA in BAL fluid: a longitudinal study in lung transplant recipients.

Authors:  G C Riise; R Andersson; T Bergström; A Lundmark; F N Nilsson; S Olofsson
Journal:  Chest       Date:  2000-12       Impact factor: 9.410

Review 8.  Human herpesvirus 6: An emerging pathogen.

Authors:  G Campadelli-Fiume; P Mirandola; L Menotti
Journal:  Emerg Infect Dis       Date:  1999 May-Jun       Impact factor: 6.883

9.  Lungs are a major organ site of cytomegalovirus latency and recurrence.

Authors:  M Balthesen; M Messerle; M J Reddehase
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

10.  Epstein-Barr virus replication within pulmonary epithelial cells in cryptogenic fibrosing alveolitis.

Authors:  J J Egan; J P Stewart; P S Hasleton; J R Arrand; K B Carroll; A A Woodcock
Journal:  Thorax       Date:  1995-12       Impact factor: 9.139

View more
  7 in total

Review 1.  Post-transplantation lymphoproliferative disorder after haematopoietic stem cell transplantation.

Authors:  Francesco Pegoraro; Claudio Favre
Journal:  Ann Hematol       Date:  2021-02-06       Impact factor: 3.673

2.  Blood and Bronchoalveolar Lavage Fluid Metagenomic Next-Generation Sequencing in Pneumonia.

Authors:  Xu Chen; Shuizi Ding; Cheng Lei; Jieli Qin; Ting Guo; Danhui Yang; Min Yang; Jie Qing; Wenlong He; Min Song; Yan Zhang; Huihui Zeng; Qingwu Qin; Lizhen Yang; Yingjiao Long; Yan Chen; Bingyin Ma; Ruoyun Ouyang; Ping Chen; Hong Luo
Journal:  Can J Infect Dis Med Microbiol       Date:  2020-08-12       Impact factor: 2.471

3.  Idiopathic pneumonia syndrome after hematopoietic cell transplantation: evidence of occult infectious etiologies.

Authors:  Sachiko Seo; Christian Renaud; Jane M Kuypers; Charles Y Chiu; Meei-Li Huang; Erik Samayoa; Hu Xie; Guixia Yu; Cynthia E Fisher; Ted A Gooley; Steven Miller; Robert C Hackman; David Myerson; Ruth H Sedlak; Yae-Jean Kim; Takahiro Fukuda; David N Fredricks; David K Madtes; Keith R Jerome; Michael Boeckh
Journal:  Blood       Date:  2015-04-27       Impact factor: 22.113

Review 4.  Clinical utility of viral load in management of cytomegalovirus infection after solid organ transplantation.

Authors:  Raymund R Razonable; Randall T Hayden
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

5.  Outcomes and prognostic factors of non-HIV patients with pneumocystis jirovecii pneumonia and pulmonary CMV co-infection: A Retrospective Cohort Study.

Authors:  Qing Yu; Peng Jia; Li Su; Hong Zhao; Chengli Que
Journal:  BMC Infect Dis       Date:  2017-06-05       Impact factor: 3.090

6.  Clinical utility of bronchoalveolar lavage cytomegalovirus viral loads in the diagnosis of cytomegalovirus pneumonitis in infants.

Authors:  Kerusha Govender; Prakash Jeena; Raveen Parboosing
Journal:  J Med Virol       Date:  2016-12-05       Impact factor: 2.327

7.  Pulmonary cytomegalovirus (CMV) DNA shedding in allogeneic hematopoietic stem cell transplant recipients: Implications for the diagnosis of CMV pneumonia.

Authors:  José Luis Piñana; Estela Giménez; María Dolores Gómez; Ariadna Pérez; Eva María González; Víctor Vinuesa; Juan Carlos Hernández-Boluda; Juan Montoro; Miguel Salavert; Mar Tormo; Paula Amat; Paula Moles; Carlos Carretero; Aitana Balaguer-Roselló; Jaime Sanz; Guillermo Sanz; Carlos Solano; David Navarro
Journal:  J Infect       Date:  2019-02-21       Impact factor: 6.072

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.